Breaking barriers to novel analgesic drug development

Nature Reviews Drug Discovery 16, 545 (2017).
doi:10.1038/nrd.2017.87

Authors: Ajay S. Yekkirala, David P. Roberson, Bruce P. Bean & Clifford J. Woolf
Acute and chronic pain complaints, although common, are generally poorly served by existing therapies. This unmet clinical need reflects a failure to develop novel classes of analgesics with superior efficacy, diminished adverse effects and a lower abuse liability than those currently available. Reasons for this

Source: Nature Reviews Drug Discovery - June 9, 2017 Category: Drugs & Pharmacology Authors: Ajay S. Yekkirala David P. Roberson Bruce P. Bean Clifford J. Woolf Tags: Review Source Type: research